Most cancer centers provide paltry resources for meeting NCI’s CCSG mandate to enhance diversity, study shows June 07, 2024Vol.50 No.23By Matthew Bin Han Ong
Conversation with The Cancer Letter Fred Hutch’s Christopher Li: Cancer centers should commit more resources to meet NCI’s Plan to Enhance Diversity requirements June 07, 2024Vol.50 No.23By Matthew Bin Han Ong
Indefinite course of osimertinib dramatically improves PFS in stage 3 EGFR-mutated NSCLC June 07, 2024Vol.50 No.23By Jacquelyn Cobb and McKenzie Prillaman
Trials & Tribulations Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists June 07, 2024Vol.50 No.23By Rebecca Sutphen
Conversation with The Cancer LetterFree ACS, ASCO combine online patient information services June 01, 2024Vol.50 No.23By Paul Goldberg
Cancer History ProjectGuest Editorial Discovery of EGFR mutations dramatically changed lung cancer treatment20th anniversary of landmark findings May 31, 2024Vol.50 No.22By Suresh S. Ramalingam
Beckerle, Ulrich, Carnival, Rathmell on navigating cancer leadership as women—and as scientists May 31, 2024Vol.50 No.22By Jacquelyn Cobb
Guest Editorial Refocusing cancer R&D for greater impact: Addressing gaps in disparities and access May 31, 2024Vol.50 No.22By Alice L. Pomponio
Guest Editorial Nursing informatics is a powerful tool to innovate tech capabilities May 31, 2024Vol.50 No.22By Lavonia Thomas
